Beyond | BYND | Long at $6.00Beyond NYSE:BYON .
The bad:
Highly speculative play.
Currently unprofitable and not forecast to become profitable over the next 3 years.
Has less than 1 year of cash runway.
The good:
Insider buying below $10 (especially in the $6-$7 range) is outweighing insider selling. The last dip below $7 saw the Officer and Director grab over $1.5 million worth of shares.
Chart setup is nice, although a move to the high $4 area is not out of the question. The gap above the current price is a great target area as the price seems to be consolidating.
Float=45M, short interest=17%. Could get squeezed, or ...
The company's blockchain assets, tZERO and Medici, are significantly more valuable than the retail ops based on current market values.
Recent layoffs may help with future profitability.
Acquisition candidate.
Santa rally?
At $6.00, NYSE:BYON is in a personal buy zone as a purely speculative play.
Target #1: $7.50
Target #2: $8.50
Target #3: $9.30
